×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BDRX – biodexa pharmaceuticals plc - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BDRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/1
08:30 am
bdrx
Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP
Medium
Report
Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP
11/24
08:30 am
bdrx
Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP
Low
Report
Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP
11/7
01:12 am
bdrx
Biodexa Pharmaceuticals (NASDAQ:BDRX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Biodexa Pharmaceuticals (NASDAQ:BDRX) had its "sell (e)" rating reaffirmed by analysts at Weiss Ratings.
11/3
08:30 am
bdrx
Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion
Medium
Report
Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion
10/27
05:31 pm
bdrx
Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight
Medium
Report
Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight
10/27
05:31 pm
bdrx
Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight
Medium
Report
Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight
10/6
08:37 am
bdrx
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025 [Yahoo! Finance]
Low
Report
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025 [Yahoo! Finance]
10/6
08:30 am
bdrx
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
Low
Report
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/24
04:06 pm
bdrx
Form 424B3 Biodexa Pharmaceuticals
High
Report
Form 424B3 Biodexa Pharmaceuticals
11/24
04:05 pm
bdrx
Form 424B3 Biodexa Pharmaceuticals
High
Report
Form 424B3 Biodexa Pharmaceuticals
11/24
11:26 am
bdrx
Form EFFECT Biodexa Pharmaceuticals
Low
Report
Form EFFECT Biodexa Pharmaceuticals
11/24
11:26 am
bdrx
Form EFFECT Biodexa Pharmaceuticals
Low
Report
Form EFFECT Biodexa Pharmaceuticals
11/17
05:05 pm
bdrx
Form POS AM Biodexa Pharmaceuticals
High
Report
Form POS AM Biodexa Pharmaceuticals
11/17
05:01 pm
bdrx
Form F-1 Biodexa Pharmaceuticals
High
Report
Form F-1 Biodexa Pharmaceuticals
11/17
04:45 pm
bdrx
Form POS AM Biodexa Pharmaceuticals
High
Report
Form POS AM Biodexa Pharmaceuticals
11/14
04:25 pm
bdrx
Form SCHEDULE 13G/A Biodexa Pharmaceuticals Filed by: C/M CAPITAL PARTNERS, LP
Medium
Report
Form SCHEDULE 13G/A Biodexa Pharmaceuticals Filed by: C/M CAPITAL PARTNERS, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: